-
September 25, 2023 TheraPsil Unveils MDMA-Assisted Psychotherapy Training ProgramThe program is aimed at meeting the rising demand for training and treatment in MDMA...
-
March 15, 2023 Canadian Patients Demand Access to Psilocybin As They Take the Federal Government to CourtEight Canadian patients one healthcare practitioner demand access to psilocybin as they take the federal...
-
November 18, 2022 Patients and Medical Professionals to Make First In-Person Appearance in Ottawa This MonthSeeking more compassionate access to psilocybin as an alternative for Canadians suffering from chronic disease,...
-
August 30, 2022 An Inside Look at the Lawsuit that could “Legalize Psychedelics in Canada”A lawsuit filed by the non-profit advocacy group TheraPsil is leading the effort to make...
-
July 28, 2022 Project Solace: The World’s Largest Medical Psilocybin Access and Data ProjectProject Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian...
-
July 28, 2021 TheraPsil’s Fight to Secure Therapeutic Psilocybin Access for All CanadiansCEO Spencer Hawkswell calls current exemptions for terminally ill under Section 56 of Canada’s Controlled...
